Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Development of optimized adenovirus-based vectors for evaluation in a mouse model of Spinal Muscular Atrophy

FY 2012-13

Summary
Spinal Muscular Atrophy (SMA) is a genetic disorder affecting 1 in 6000 live births. In its most severe form, children with SMA are never able to sit and succumb to the disease within the first 2 years of life. The disease is caused by mutations in the gene encoding a protein called survival motor neuron (SMN). This protein is essential for proper function and health of motor neurons and, in the absence of SMN, motor neurons die leading to muscle weakness and atrophy. Currently there is no known cure. In our studies, we are using attenuated viruses to deliver a good copy of the SMN gene to a mouse model of SMA in order to achieve disease correction. In the first part of our research, we will screen a panel of viruses that infect cells through different routes to identify the virus that targets infection to motor neurons. In the second part of the research, we will use the virus identified above to deliver the SMN gene to a mouse model of SMA. These mice will be monitored at varying times after gene delivery for overall health and muscle strength. We believe that this therapy will improve motor neuron and muscle function in the animals, and will dramatically extend their lifespan (untreated animals typically only survive one month). These studies will provide important preliminary preclinical data that may help in developing a new therapeutic approach for treatment of SMA.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
279779
Name
McFall Emily R
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Development of optimized adenovirus-based vectors for evaluation in a mouse model of Spinal Muscular Atrophy
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adenovirus; Dissection; Gene Therapy; In Vitro And In Vivo Infections; Ip And Iv Injections; Mouse Model; Solid And Liquid Overlays; Spinal Muscular Atrophy; Titers; Viral Purification
Abstract
Spinal Muscular Atrophy (SMA) is a genetic disorder affecting 1 in 6000 live births. In its most severe form, children with SMA are never able to sit and succumb to the disease within the first 2 years of life. The disease is caused by mutations in the gene encoding a protein called survival motor neuron (SMN). This protein is essential for proper function and health of motor neurons and, in the absence of SMN, motor neurons die leading to muscle weakness and atrophy. Currently there is no known cure. In our studies, we are using attenuated viruses to deliver a good copy of the SMN gene to a mouse model of SMA in order to achieve disease correction. In the first part of our research, we will screen a panel of viruses that infect cells through different routes to identify the virus that targets infection to motor neurons. In the second part of the research, we will use the virus identified above to deliver the SMN gene to a mouse model of SMA. These mice will be monitored at varying times after gene delivery for overall health and muscle strength. We believe that this therapy will improve motor neuron and muscle function in the animals, and will dramatically extend their lifespan (untreated animals typically only survive one month). These studies will provide important preliminary preclinical data that may help in developing a new therapeutic approach for treatment of SMA.
Competitiondate
201302
Approvedterm2
1 yr 0 mth
Pinamesdelim
McFall, Emily R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~